Year All2024202320222021202020192018201720162015201420122011 Nov 2, 2022 Ardelyx, Inc. Reports Employment Inducement Grants Oct 31, 2022 Ardelyx Collaboration Partner, Kyowa Kirin, Announces Submission of New Drug Application for Tenapanor for Hyperphosphatemia in Japan Oct 27, 2022 Ardelyx to Report Third Quarter 2022 Financial Results on November 3, 2022 Oct 24, 2022 Ardelyx to Present Poster Presentations on IBSRELA® (tenapanor) for Adult Patients with IBS-C at the American College of Gastroenterology 2022 Annual Scientific Meeting Oct 20, 2022 Ardelyx Announces Poster Presentations on XPHOZAH® (tenapanor) at ASN's Kidney Week 2022 Sep 30, 2022 Ardelyx, Inc. Reports Employment Inducement Grants Sep 6, 2022 Ardelyx to Participate in Upcoming Investor Conferences Aug 4, 2022 Ardelyx Reports Second Quarter 2022 Financial Results and Recent Business Highlights Aug 2, 2022 Ardelyx to Present at the 2022 Wedbush PacGrow Healthcare Conference Jul 28, 2022 Ardelyx to Report Second Quarter 2022 Financial Results on August 4, 2022